The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis
Open Access
- 6 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Abstract
Thalidomide is widely used for several diseases; however, it causes malformations in embryos exposed during pregnancy. The complete understanding of the mechanisms by which thalidomide affects the embryo development has not yet been obtained. The phenotypic similarity makes TE a phenocopy of syndromes caused by mutations in ESCO2, SALL4 and TBX5 genes. Recently, SALL4 and TBX5 were demonstrated to be thalidomide targets. To understand if these genes act in the TE development, we sequenced them in 27 individuals with TE; we verified how thalidomide affect them in human pluripotent stem cells (hPSCs) through a differential gene expression (DGE) analysis from GSE63935; and we evaluated how these genes are functionally related through an interaction network analysis. We identified 8 variants in ESCO2, 15 in SALL4 and 15 in TBX5. We compared allelic frequencies with data from ExAC, 1000 Genomes and ABraOM databases; eight variants were significantly different (p < 0.05). Eleven variants in SALL4 and TBX5 were previously associated with cardiac diseases or malformations; however, in TE sample there was no association. Variant effect prediction tools showed 97% of the variants with potential to influence in these genes regulation. DGE analysis showed a significant reduction of ESCO2 in hPSCs after thalidomide exposure.Keywords
This publication has 46 references indexed in Scilit:
- SNPs Identified as Modulators of ECG Traits in the General Population Do Not Markedly Affect ECG Traits during Acute Myocardial Infarction nor Ventricular Fibrillation Risk in This ConditionPLOS ONE, 2013
- Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in BrazilPLOS ONE, 2011
- Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cellsGenome Research, 2008
- sall4acts downstream oftbx5and is required for pectoral fin outgrowthDevelopment, 2006
- A Novel Hypothesis for Thalidomide-Induced Limb Teratogenesis: Redox Misregulation of the NF-κB PathwayAntioxidants & Redox Signaling, 2004
- Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential usesTeratology, 1999
- Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene familyNature Genetics, 1997
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.Journal of Experimental Medicine, 1991
- Phenocopies.Journal of Medical Genetics, 1973